{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:56:51Z","timestamp":1781207811350,"version":"3.54.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the United States (U.S.), fentanyl remains the leading drug associated with opioid-related deaths. Many analogs of fentanyl have been identified and linked to the opioid overdose epidemic. After core-structure scheduling of illicitly manufactured fentanyl (IMF) and related products, para-fluorofentanyl (p-FF) reemerged with varied prevalence in the U.S. Xylazine also emerged as a cutting agent in IMF. The aim of this study was to describe the prevalence and trend use patterns of fentanyl, p-FF, and xylazine in a case series from 2021 to 2023 in the state of Florida. A three-year retrospective analysis of data was conducted. A total of 8121 cases were submitted for analysis over the period of study. Among them, 1530 cases (18.8%) tested positive for fentanyl in one or more of the specimens submitted for these cases. The age of the decedents ranged 16\u201385\u2009years, with the majority being White males. The concentration range of fentanyl in the blood specimens (n\u2009=\u20091358) analyzed was 2.5\u2013579\u2009ng\/mL. p-FF was detected with fentanyl in 164 postmortem blood specimens with a concentration range of 2.5\u201365\u2009ng\/mL. Xylazine was identified in the urine of 391 decedents. The combination of fentanyl, p-FF, and xylazine was detected in 70 cases. When fentanyl co-occurred with both xylazine and p-FF, it was primarily observed with benzodiazepines, cocaine, methamphetamine, and other opioids. This study aimed to provide a better understanding of the fentanyl analog and adulterant prevalence in Florida.<\/jats:p>","DOI":"10.1093\/jat\/bkag035","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:24:11Z","timestamp":1780313051000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of\n                    <i>p<\/i>\n                    -fluorofentanyl and xylazine in postmortem fentanyl casework"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-650X","authenticated-orcid":false,"given":"Marco","family":"Ballotari","sequence":"first","affiliation":[{"name":"Forensic Toxicology Laboratory, Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine , Gainesville, FL 32607,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3747-5379","authenticated-orcid":false,"given":"Michael T","family":"Truver","sequence":"additional","affiliation":[{"name":"Forensic Toxicology Laboratory, Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine , Gainesville, FL 32607,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6846-7677","authenticated-orcid":false,"given":"Jennifer L","family":"Hoyer","sequence":"additional","affiliation":[{"name":"Forensic Toxicology Laboratory, Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine , Gainesville, FL 32607,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5799-1787","authenticated-orcid":false,"given":"Bruce A","family":"Goldberger","sequence":"additional","affiliation":[{"name":"Forensic Toxicology Laboratory, Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine , Gainesville, FL 32607,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-7987","authenticated-orcid":false,"given":"Chris W","family":"Chronister","sequence":"additional","affiliation":[{"name":"Forensic Toxicology Laboratory, Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine , Gainesville, FL 32607,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2026061115165796900_bkag035-B1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"2026061115165796900_bkag035-B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.12.004","article-title":"Fentanyl and fentanyl-analog involvement in drug-related deaths","volume":"196","author":"Dai","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2026061115165796900_bkag035-B3","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2013United States, 2019\u20132020","volume":"70","author":"O\u2019Donnell","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026061115165796900_bkag035-B4","author":"Drug Enforcement Administration","year":"2025"},{"key":"2026061115165796900_bkag035-B5","author":"Florida Department of Law Enforcement","year":"2024"},{"key":"2026061115165796900_bkag035-B6","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00414-024-03263-7","article-title":"Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities","volume":"138","author":"Giorgetti","year":"2024","journal-title":"Int J Legal Med"},{"key":"2026061115165796900_bkag035-B7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/jat\/bky035","article-title":"Analysis of fentanyl and 18 novel fentanyl analogs and metabolites by LC\u2013MS-MS, and report of fatalities associated with methoxyacetylfentanyl and cyclopropylfentanyl","volume":"42","author":"Fogarty","year":"2018","journal-title":"J Anal Toxicol"},{"key":"2026061115165796900_bkag035-B8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/jat\/bkac014","article-title":"Toxicological analysis of fluorofentanyl isomers in postmortem blood","volume":"46","author":"Truver","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026061115165796900_bkag035-B9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/dta.2822","article-title":"In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis","volume":"12","author":"Hassanien","year":"2020","journal-title":"Drug Test Anal"},{"key":"2026061115165796900_bkag035-B10","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/dta.2393","article-title":"Analysis of fentanyl analogs and novel synthetic opioids in blood, serum\/plasma, and urine in forensic casework","volume":"10","author":"Moody","year":"2018","journal-title":"Drug Test Anal"},{"key":"2026061115165796900_bkag035-B11","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/1556-4029.15283","article-title":"Emergence of fentanyl-related deaths in Travis County, Texas and surrounding areas: a retrospective review of postmortem fentanyl-related drug toxicities from 2020 to 2022","volume":"68","author":"Ellefsen","year":"2023","journal-title":"J Forensic Sci"},{"key":"2026061115165796900_bkag035-B12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/ADM.0000000000001132","article-title":"Widespread distribution of xylazine detected throughout the united states in healthcare patient samples","volume":"17","author":"Holt","year":"2023","journal-title":"J Addict Med"},{"key":"2026061115165796900_bkag035-B13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/1556-4029.15375","article-title":"Prevalence of xylazine in overdose cases: an analysis of Miami-Dade County medical examiner case data","volume":"68","author":"Potoukian","year":"2023","journal-title":"J Forensic Sci"},{"key":"2026061115165796900_bkag035-B14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jat\/bkac049","article-title":"Xylazine: pharmacology review and prevalence and drug combinations in forensic toxicology casework","volume":"46","author":"Kacinko","year":"2022","journal-title":"J Anal Toxicol"},{"key":"2026061115165796900_bkag035-B15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/PAF.0000000000000787","article-title":"Proliferation of novel synthetic opioids in postmortem investigations after core-structure scheduling for fentanyl-related substances","volume":"43","author":"Papsun","year":"2022","journal-title":"Am J Forensic Med Pathol"},{"key":"2026061115165796900_bkag035-B16","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/1556-4029.14712","article-title":"Fentanyl-related substance scheduling as an effective drug control strategy","volume":"66","author":"Weedn","year":"2021","journal-title":"J Forensic Sci"},{"key":"2026061115165796900_bkag035-B17","author":"Drug Enforcement Administration, Diversion Control Division: Drug and Chemical Evaluation Section","year":"2021"},{"key":"2026061115165796900_bkag035-B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int"},{"key":"2026061115165796900_bkag035-B19","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/1556-4029.15295","article-title":"Fatal intoxication involving 2-methyl AP -237","volume":"68","author":"Truver","year":"2023","journal-title":"J Forensic Sci"},{"key":"2026061115165796900_bkag035-B20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/jat\/bkae059","article-title":"A postmortem case report involving fentanyl, desalkylgidazepam, and bromazolam","volume":"48","author":"Ballotari","year":"2024","journal-title":"J Anal Toxicol"},{"key":"2026061115165796900_bkag035-B21","author":"Drug Enforcement Administration","year":"2024"},{"key":"2026061115165796900_bkag035-B22","author":"Congress Research Service","year":"2024"},{"key":"2026061115165796900_bkag035-B23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.15585\/mmwr.mm7104a3","article-title":"Notes from the field: increased incidence of fentanyl-related deaths involving para -fluorofentanyl or Metonitazene\u2013Knox County, Tennessee, November 2020\u2013August 2021","volume":"71","author":"Trecki","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026061115165796900_bkag035-B24","doi-asserted-by":"publisher","first-page":"109380","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"2026061115165796900_bkag035-B25","doi-asserted-by":"publisher","first-page":"108314","DOI":"10.1016\/j.drugalcdep.2020.108314","article-title":"Steep increases in fentanyl-related mortality west of the Mississippi River: Recent evidence from county and state surveillance","volume":"216","author":"Shover","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2026061115165796900_bkag035-B26","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/jat\/bkad052","article-title":"Comparative toxicology of syringe exchange and postmortem blood samples in the District of Columbia: trends and affinity analysis","volume":"47","author":"Turley","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026061115165796900_bkag035-B27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj Prev"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag035\/68463564\/bkag035.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/6\/bkag035\/68463564\/bkag035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/6\/bkag035\/68463564\/bkag035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:17:05Z","timestamp":1781205425000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag035\/8700942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag035","relation":{},"ISSN":["1945-2403"],"issn-type":[{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"bkag035"}}